RECORD
The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement: an EQUATOR-registered reporting extension of STROBE that adds 13 routinely-collected-data items (data sources, codes and algorithms, validation, linkage, population selection, flow diagram) for studies using EHR, administrative claims, and disease registries.
On this page
What it is
RECORD (REporting of studies Conducted using Observational Routinely-collected health Data) is a reporting guideline published in 2015 (Benchimol et al., PLOS Medicine) that extends the STROBE statement for observational research using data not collected for research purposes: electronic health records, administrative claims, disease and product registries, and linkages among them. It is not a new checklist but an extension — authors must satisfy the 22 STROBE items and the RECORD additions. The RECORD items target the failure points specific to routinely-collected data: explicit naming of the data source(s) in the title/abstract (RECORD 1.1–1.3), the population-selection process and the codes/algorithms used to define populations, exposures, outcomes, and confounders, with their validation (RECORD 6.1–6.3, 7.1), data linkage and the linkage quality assessment (RECORD 12.1–12.3), a population flow diagram, and statements on data cleaning, access, and availability of code lists. RECORD is maintained by its author group and hosted in the EQUATOR Network library (record-statement.org). The principal published extension is RECORD-PE (Langan et al., 2018, BMJ) for pharmacoepidemiology studies of medication effects. A reporting extension for NLP-derived variables (provisionally "RECORD-NLP") has been proposed but is not yet a finalized published checklist as of 2026 — treat it as anticipated guidance, not an established standard.
When to use
Reach for RECORD whenever a non-interventional study analyses routinely-collected health data and the output is destined for a peer-reviewed journal, an HTA/payer dossier, a regulatory submission (FDA RWE program, EMA), or a registered protocol. It is the reporting backbone for claims, EHR, registry, linked, and multi-database studies. Decision rules for which member of the family applies:
- If the study evaluates the effect of a medication, vaccine, or other intervention (comparative safety or effectiveness, drug utilisation), use RECORD-PE — it adds pharmacoepidemiology items (exposure windows, new-user/active-comparator design, time-zero, washout) that plain RECORD does not enforce.
- If key variables (phenotypes, outcomes) are extracted from clinical free text via natural-language processing, document the text source, NLP model/method, and validation of the derived phenotype (the proposed RECORD-NLP extension is not yet finalized — until it is, report these elements under RECORD/RECORD-PE plus the relevant NLP-validation literature).
- If the data were collected for research (prospective cohort, primary-data registry trial, surveys), plain STROBE (or the relevant STROBE extension) suffices — RECORD's data-provenance items add little.
- RECORD is a reporting tool. For design pre-specification of an RWD study use a protocol template (HARPER, STaRT-RWE, ENCePP Checklist); for HTA reference-case alignment use NICE/CADTH frameworks. RECORD governs how you report what you did, not how you design it.
What it requires
The substantive item clusters RECORD enforces, framed for real-world data:
- Data-source transparency (RECORD 1.1, 6.1–6.2): name every database, the dates and geographic/health-system coverage, and the population-selection cascade from source to analytic cohort.
- Data fitness-for-use (RECORD 6.3, 13): completeness, representativeness, and the cleaning/validation steps — the reader must be able to judge whether the data can answer the question.
- Phenotype / algorithm transparency and validation (RECORD 6.1, 7.1): a complete list of codes and algorithms used to define populations, exposures, outcomes, and confounders, with references to validation (PPV, sensitivity) where available. Code lists should be made available.
- Population flow and attrition (RECORD 13.1): a flow diagram from the source population through each eligibility and exclusion step to the analytic sample.
- Data linkage and its quality (RECORD 12.1–12.3): linkage methods, the proportion linked, and the impact of incomplete linkage on the study population.
- Access and reproducibility (RECORD 22.1): how others could access the data/code and any approvals required. RECORD does not itself prescribe estimands, confounding control, or sensitivity analysis — but because it requires you to report exposure/outcome definitions, time windows, and analytic decisions transparently, applying it well forces the underlying RWE methods (time-zero alignment, active-comparator design, hdPS, quantitative bias analysis) to be specified and defended.
When NOT to use — limitations and common misapplications
- RECORD is a reporting checklist, not a risk-of-bias instrument and not a quality score. Ticking every item certifies completeness of reporting, not validity. A perfectly RECORD-compliant paper can still be hopelessly confounded. For critical appraisal use ROBINS-I, the Newcastle-Ottawa Scale, or ISPE/ISPOR good-practice recommendations — not RECORD.
- Completing the checklist does not make an observational study causal. Transparent reporting of an immortal-time-biased or prevalent-user design is still a biased design, fully reported.
- Using STROBE alone for routinely-collected data. STROBE omits the data-provenance, code-list, validation, and linkage items that are the whole point of RECORD; a claims/EHR study reported only to STROBE will be sent back by informed reviewers.
- Using plain RECORD where RECORD-PE is required. A comparative drug-safety study reported to RECORD but not RECORD-PE will under-report exposure definition, new-user/active-comparator design, time-zero, and washout — the items that determine whether the comparison is interpretable.
- Wrong extension for the design (e.g., RECORD where an NLP-derived phenotype demands RECORD-NLP).
- Checklist-as-theater. Appending a completed RECORD table to a manuscript when the protocol never pre-specified the code lists, validation, or analytic decisions is retrofitting, not transparency. Pre-specify in the protocol (HARPER/STaRT-RWE), then report against RECORD.
How it maps to this catalog
Each RECORD requirement is implemented by one or more concepts in this repo:
- Data fitness (RECORD 6.1–6.3, 13) → `fit-for-purpose-data-assessment-rwe` and `database-feasibility-attrition-funnel-rwe`; payer-specific completeness via `medicare-ffs-ma-commercial-claims-differences-rwe` and `claims-analysis`.
- Population/exposure/outcome codes and algorithms with validation (RECORD 6.1, 7.1) → `diagnosis-phenotype-algorithm-1ip-2op-time-window-rwe`, `claims-outcome-algorithm-ppv-sensitivity-rwe`, `ehr-phenotyping-algorithms-rwe`, and `algorithm-validation`.
- Time-zero / index-date alignment and washout (reported under design/exposure) → `time-zero-index-date-alignment-rwe`, `washout-clean-lookback-period-rwe`, `active-comparator-new-user`.
- Estimands and intercurrent events → `estimands-ate-att-intercurrent-events-rwe`; design emulation via `target-trial-emulation`.
- Confounding control to report → `high-dimensional-propensity-score-hdps-rwe`, `propensity-score-methods-psm-iptw`.
- Population flow / attrition (RECORD 13.1) → `attrition-and-loss-to-follow-up-rwe` and `continuous-enrollment-observable-time-rwe`.
- Data linkage and its quality (RECORD 12.1–12.3) → `linked-data` and, for the mother-infant case, `mother-infant-linkage-rwe`.
- Sensitivity / quantitative bias analysis to report → `e-value-sensitivity-analysis` and `quantitative-bias-analysis-toolkit-rwe`.
- Reporting visuals → `visualizations-pharmacoepidemiology-rwe` for the population flow diagram and balance/diagnostic plots.
Applied note (claims/EHR/registry RWE)
In a Medicare + commercial claims comparative-safety study, RECORD compliance means: name each database and its dates and benefit type in the abstract; report the exact NDC/ICD/CPT code lists and the phenotype rules (e.g., 1 inpatient or 2 outpatient diagnoses within a window) for exposures, outcomes, and confounders, with PPV/sensitivity references; show the population flow from enrollees through continuous-enrollment and washout filters to the analytic cohort; and, because it is a drug study, report against RECORD-PE so that the new-user/active-comparator structure, time-zero, and exposure windows are explicit. Where Medicare Advantage encounter completeness or fee-for-service claim capture affects the cohort, state it under data fitness — that disclosure is exactly what RECORD 6.3 exists to elicit.
Citations
- [1]Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement. PLOS Medicine. 2015;12(10):e1001885.
- [2]von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. PLoS Medicine. 2007;4(10):e296.
- [3]Langan SM, Schmidt SAJ, Wing K, et al. The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE). BMJ. 2018;363:k3532.